Pharmacopeia Biotechnology

Pharmacopeia was a public biotechnology company that pioneered the field of small molecule combinatorial chemistry.

Pharmacopeia was founded by Larry Bock and Drs. Michael Wigler, Clark Still and Jack Chabala.

Pharmacopeia went public in 1996 and was acquired by Ligand Pharmaceuticals on 12/23/2008.

References

External links


  This article uses material from the Wikipedia page available here. It is released under the Creative Commons Attribution-Share-Alike License 3.0.


Pharmacopeia_biotechnology